BioCentriq
BioCentriq is a global cell-based therapy Contract Development and Manufacturing Organization (CDMO) that accelerates the delivery of innovative cell therapies by translating, optimizing, and scaling processes for GMP manufacture. They offer end-to-end solutions for cell therapy development and manufacturing, including process development, manufacturing, and analytical testing. BioCentriq is committed to supporting partners in advancing life-changing therapies from concept to clinic.
Funding Round: Series A
Funding Amount: $29.2M
Date: 03-Jan-2024
Investors:
Markets: Healthtech, Biotechnology
HQ: Newark, New Jersey, United States
Founded: 2019
Website: https://biocentriq.com/
LinkedIn: https://www.linkedin.com/company/biocentriq
Twitter: https://twitter.com/BioCentriq
Crunchbase: https://www.crunchbase.com/organization/biocentriq
Leave a Comment
Comments
No comments yet.